Affordable Access

Access to the full text

Intracranial VCAM1 at time of mechanical thrombectomy predicts ischemic stroke severity

Authors
  • Maglinger, Benton1
  • Sands, Madison1
  • Frank, Jacqueline A.1, 2
  • McLouth, Christopher J.1
  • Trout, Amanda L.1, 2
  • Roberts, Jill M.2, 1, 1
  • Grupke, Stephen3
  • Turchan-Cholewo, Jadwiga1, 2
  • Stowe, Ann M.1, 1, 2
  • Fraser, Justin F.1, 2, 1, 1, 1
  • Pennypacker, Keith R.1, 2, 1
  • 1 University of Kentucky, Lexington, KY, USA , Lexington (United States)
  • 2 University of Kentucky, Lexington, KY, 40536, USA , Lexington (United States)
  • 3 Covenant Medical Center, Lubbock, TX, USA , Lubbock (United States)
Type
Published Article
Journal
Journal of Neuroinflammation
Publisher
Springer (Biomed Central Ltd.)
Publication Date
May 11, 2021
Volume
18
Issue
1
Identifiers
DOI: 10.1186/s12974-021-02157-4
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundEmergent large vessel occlusion (ELVO) strokes are devastating ischemic vascular events for which novel treatment options are needed. Using vascular cell adhesion molecule 1 (VCAM1) as a prototype, the objective of this study was to identify proteomic biomarkers and network signaling functions that are potential therapeutic targets for adjuvant treatment for mechanical thrombectomy.MethodsThe blood and clot thrombectomy and collaboration (BACTRAC) study is a continually enrolling tissue bank and registry from stroke patients undergoing mechanical thrombectomy. Plasma proteins from intracranial (distal to clot) and systemic arterial blood (carotid) were analyzed by Olink Proteomics for N=42 subjects. Statistical analysis of plasma proteomics used independent sample t tests, correlations, linear regression, and robust regression models to determine network signaling and predictors of clinical outcomes. Data and network analyses were performed using IBM SPSS Statistics, SAS v 9.4, and STRING V11.ResultsIncreased systemic (p<0.001) and intracranial (p=0.013) levels of VCAM1 were associated with the presence of hypertension. Intracranial VCAM1 was positively correlated to both infarct volume (p=0.032; r=0.34) and edema volume (p=0.026; r=0.35). The %∆ in NIHSS from admittance to discharge was found to be significantly correlated to both systemic (p=0.013; r = −0.409) and intracranial (p=0.011; r = −0.421) VCAM1 levels indicating elevated levels of systemic and intracranial VCAM1 are associated with reduced improvement of stroke severity based on NIHSS from admittance to discharge. STRING-generated analyses identified biologic functional descriptions as well as function-associated proteins from the predictive models of infarct and edema volume.ConclusionsThe current study provides novel data on systemic and intracranial VCAM1 in relation to stroke comorbidities, stroke severity, functional outcomes, and the role VCAM1 plays in complex protein-protein signaling pathways. These data will allow future studies to develop predictive biomarkers and proteomic targets for drug development to improve our ability to treat a devastating pathology.

Report this publication

Statistics

Seen <100 times